HeiQ launches anti-viral textile technology tested to be effective against coronavirus HeiQ Viroblock NPJ03

Zurich, Switzerland, March 17, 2020 HeiQ, winner of the Swiss Technology Award and the Swiss Environmental Award, launches HeiQ Viroblock NPJ03, an antiviral and antibacterial fabric treatment technology tested to be

effective against coronavirus.

For 15 years, HeiQ has created a brilliant history of innovation, helping brands improve fabric products. To support the fight against coronavirus, HeiQ has launched HeiQ Viroblock NPJ03 (referred to as “Viroblock”), an antiviral and antibacterial fabric treatment technology. Mask tests have proven that this therapy is effective against human coronavirus (229E), significantly

increasing the antiviral log reduction value from 2.90 for untreated masks to 4.48, and reducing viral infectivity by more than

99.99%. (Note: A logarithmic reduction of 2 is equivalent to an effectiveness of 100 times.) Carlo Centonze, CEO of HeiQ Group, said: “HeiQ Scientific Advisory Board’s >

Virologist Dr. Thierry Pelet brings a wealth of knowledge that accelerates our efforts to solve pressing global epidemic problems

Our goal is to prevent fabrics Become a host surface for the spread of harmful viruses and bacteria,

and contribute to reducing the risk and speed of contamination and transmission.”

The World Health Organization (World Health Organization) said that the new coronavirus The ambush period ranges from 1 to 14

days. Social distancing and wearing masks are common measures taken by people in countries such as South Korea and Taiwan to avoid the spread of the virus. Chinese protective mask manufacturer Suzhou Bolis adopts Viroblock. Treated masks will be available as early as April this year. Many international textile manufacturers, including US tights and socks maker Kayser-Roth and Chinese brand Lufeng, are evaluating Viroblock for other types of fabrics.

Dr. Pellet said: “HeiQ was able to quickly complete such a complex innovation and bring this breakthrough to a globally important product in such a short period of time. I’m impressed.”

Viroblock’s unique combination of vesicle and silver technology is designed to inhibit the growth and retention of bacteria and viruses. HeiQ vesicle technology targets lipid-developed viruses such as coronaviruses and quickly kills them, while HeiQ silver technology inhibits the replication of bacteria and viruses. Viroblock can be used on a variety of fabric surfaces, including masks, air filters, medical clothing, curtains, etc.

Scientists have identified seven human coronaviruses so far. 229E and Covid-19 are two of them.

In addition to testing on human coronavirus (229E), HeiQ Viroblock NPJ03 has also been tested and confirmed

to significantly reduce the risk of influenza viruses H1N1, H5N1, H7N9 and respiratory syncytial virus ( RSV) contagiousness.

AAAGFHTRYKUYIU7OUP

Disclaimer:

Disclaimer: Some of the texts, pictures, audios, and videos of some articles published on this site are from the Internet and do not represent the views of this site. The copyrights belong to the original authors. If you find that the information reproduced on this website infringes upon your rights, please contact us and we will change or delete it as soon as possible.